TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ACMR

Acm Research Inc

Technology · Semiconductor Equipment & Materials · listed since 2017

67.80$ +4.6% vs. previous close Closing price · As of: Sep 17, 2026
🔔 Watch stock
Add to watchlist

Assessment

Our Rating

A journalistic assessment by our editorial team at the time of the deep dive — it rates the company, not the entry point. Not investment advice and not a solicitation to buy or sell.

Open questions

The business works in principle, but one material question is open. As long as it stays open, our findings do not carry a quality verdict.

Why this colour

Whoever buys today is betting that China's chip fabs keep localizing, that export controls are not tightened and that the market keeps ignoring the holding floor — and pays 78 times trailing earnings with negative free cash flow for it. Whoever waits checks three things in every quarterly report (10-Q): does the core cleaning business return to growth, does operating cash flow turn sustainably positive, and does the regulatory status (Entity List, export rules) stay stable? The decision is yours.

What the thesis turns on

Assessment: Opportunities & Risks

ACM Research is a genuine growth company in the world's most strategically important equipment market — and at the same time the purest China bet you can make with a Nasdaq ticker: 99.6 percent of revenue from mainland China, the operating subsidiary on the U.S. Entity List, a holding with a 74.6 percent stake and legally narrowed access to the cash, plus negative free cash flow despite record profit. Whoever invests here buys the localization of Chinese chipmaking as tailwind and geopolitics as a permanent risk — at 78 times trailing earnings. Not investment advice.

Growth & profitability

Revenue more than tripled in four years ($259.8 → $901.3 million through 2025), $94.1 million in net income for ACM Research, Q1 2026 up 34 percent and a $145 million development budget — the business is real and profitable (10-K 2025, 10-Q as of 03/31/2026). But: gross margin fell from 50.1 to 44.4 percent, and earnings per share declined.

China clumping & Entity List

99.6 percent of revenue from mainland China, four unnamed customers with a 52.2 percent revenue share, and the operating subsidiaries ACM Shanghai and ACM Korea have been on the BIS Entity List since December 2, 2024 — the business model hangs on the continuation of a bloc-building that can also hit it harder at any time (10-K 2025).

Holding structure & access to the cash

ACM Research holds only 74.6 percent of ACM Shanghai (down from 91.7 percent in 2019); Chinese law restricts dividends, the $623 million from the September 2025 private offering is per the 10-K generally not available to the holding, and a quarter of the profit belongs to minority shareholders — the Nasdaq shareholder buys a claim on a claim.

Cash flow & balance-sheet quality

Negative $10.3 million operating and negative $67.1 million free cash flow in 2025 despite record profit; $702.6 million of inventories and an allowance for credit losses up from $4.8 to $32.8 million stand against a comfortable $1,132.6 million cash position and an Altman Z around 9.7 (12/31/2025; data as of July 17, 2026) — solidly financed, but the business ties up money continuously.

Valuation, governance & technicals

A stage-2 uptrend, relative strength of 97 and 25 scanner hits meet a trailing P/E around 78 after a quadrupling, 20-fold insider voting rights (62.3 percent of the votes), 18 insider sales against zero buys and daily swings around 10 percent (data as of July 17, 2026) — first-class momentum at a price that forgives little.

Worth Noting

ACMR reached our research list via the momentum/stage-2 run of July 17, 2026, with 25 scanner hits (incl. Stan Weinstein stage 2, RS leaders ≥90, Minervini trend template) — the trend strength is the hook of this analysis, not its verdict.

Scanner metrics (P/E, P/S, Piotroski, Altman Z, fundamental grade, insider transactions) are computed from trailing twelve-month figures as of the July 17, 2026 data cut-off; the 2025 margin and EPS decline is baked in, a potential new customer investment cycle naturally is not.

Price and valuation figures are dated to July 17, 2026 (about $107, market value roughly $7.3 billion); analyses are evergreen, daily prices are not a buy argument. The voting-power figure (62.3 percent for Class B) comes from the 10-K for 2025 with its stated record date of February 25, 2025.

Stock Watch

This analysis is as of August 26, 2026. Stock Watch will tell you what's changed at ACMR since then.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Price history

Chart

Interactive price chart (TradingView).

52-week range: 29.70 $ to 126.90 $ · Last price: 67.80 $ (As of: September 17, 2026)

Key figures

Key figures at a glance

Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.

Basics

Market Cap ?The value of the entire company on the market: share price times total shares outstanding. 4.6$B
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 65m
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 95.1%
Beta ?Volatility versus the overall market: 1 = moves like the market, 2 = twice as much, under 1 = calmer than the market. 2.0

Performance

Perf. 1M ?Price performance over the last month. 28.00%
Perf. 3M ?Price performance over the last 3 months. 196.70%
Perf. 6M ?Price performance over the last 6 months. 196.50%
YTD Performance (%) ?Price performance since the start of the year (Year to Date). 151.30%
52-Week-High Distance ?How far the price sits below its highest point over the last 52 weeks. 0% means the stock is at its year high. -4.1%
Perf. 1Y ?Price performance over the last 12 months. 100.74%
Perf. 3Y ?Price performance over the last 3 years. 336.66%
Perf. 5Y ?Price performance over the last 5 years. 98.55%
Perf. Since Inception ?Price performance since the first available trading day (11/02/2017) — with a complete history, that is since the IPO. 3,530.47%

Technical Indicators

MA 38 Days ?Moving average of the last 38 trading days: the smoothed price path. A price above it signals short-term strength. 76.10$
MA 50 Days ?Moving average of the last 50 trading days — the most widely watched medium-term trend line. 79.90$
MA 200 Days ?Moving average of the last 200 trading days — the dividing line between a long-term uptrend and downtrend. 64.80$
RSI (14) ?Relative Strength Index over 14 days, scale 0 to 100: above 70 counts as overbought, below 30 as oversold. A hint on timing, not a verdict on the company. 40.7
Volatility 30 Days ?Price swings over the last 30 trading days, annualized. The higher the value, the more the price fluctuates. 62.8%
Volatility 250 Days ?Price swings over the last 250 trading days (roughly one market year), annualized. 87.1%

Calculated from the price history · as of 09/18/2026

Valuation

P/E ?Price-to-earnings ratio: how many years of profit does the stock cost? The lower, the cheaper the valuation. No earnings means no P/E. 48.7
Forward P/E ?P/E based on expected earnings for the next 12 months instead of past earnings — analysts' bet on the future. 23.9
PEG ?P/E divided by expected earnings growth: puts valuation in relation to growth. Around 1 is considered fair, well above that is pricey.
P/B ?Price-to-book ratio: market value relative to book equity. 2.9
P/S ?Price-to-sales ratio: market value divided by annual sales. Important for companies that aren't (yet) profitable. 4.5
EV/EBITDA ?Enterprise value including debt (EV) relative to operating profit before depreciation and amortization (EBITDA) — more comparable than P/E because debt counts too. Extreme values arise when EBITDA is near zero. 12.7
Price/FCF ?Market value divided by free cash flow: how many years of freely available cash does the stock cost? More honest than P/E because cash flow is harder to dress up.

Profitability

Gross Margin ?Gross margin: what's left of sales after only direct production costs are deducted — the product's pricing power. 43.8%
EBIT Margin ?EBIT margin: operating profit as a percentage of sales — the earning power of the core business before interest and taxes. 15.6%
Net Margin ?Net margin: what's left of sales as profit after ALL costs, interest, and taxes. 14.5%
Return on Equity ?Return on equity: how much profit does the company generate per year on shareholders' equity? 7.6%
Return on Assets ?Return on assets: how much profit the company generates from its total assets (equity and debt combined). 3.2%

Balance Sheet & Safety

Equity Ratio ?Equity ratio: equity as a share of total assets. The higher, the more resilient the balance sheet. 51.6%
Debt/Equity ?Leverage ratio: financial debt divided by equity. Under 1 is generally seen as solid; negative values mean negative equity. 0.2
Altman Z″ ?Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks. fortress balance sheet 9.66
Piotroski ?Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag. 3 out of 9

Growth

Sales Growth Last Quarter ?Sales growth in the most recently reported quarter versus the same quarter a year ago (YoY). 34.20%
EPS Growth Last Quarter ?Growth in earnings per share in the most recently reported quarter versus the same quarter a year ago (YoY). -18.70%
Sales Growth (Year) ?Sales growth in the last fiscal year versus the year before. 15.24%
Forward Sales Growth ?Sales growth analysts expect over the next 12 months — an estimate, not a guarantee. 25.39%
Forward EPS Growth ?Earnings-per-share growth analysts expect over the next 12 months — an estimate, not a guarantee.

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage ?Weinstein phases 1 through 4: 1 = basing, 2 = uptrend (the only buy phase), 3 = topping, 4 = downtrend. Measured against the 30-week line. 2
RS Rating ?Relative strength from 1 to 99: an RS of 95 means the stock has outperformed 95% of all stocks. Top 10% 97
EPS Rating ?Earnings growth rating from 1 to 99 versus all stocks — high values mean above-average earnings growth. 24
Fundamental Rating ?Our own Fundamental Rating: 0 to 100 points with an A+ to F grade. 50 points is the average across the universe, 100 the best possible score. It scores growth, earnings surprises, analyst estimates, margins, cash flow, and balance-sheet safety — every stock percentile-ranked against all others. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below. B (66 out of 100)

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Comparison

Industry comparison

The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.

Industry: Semiconductor Equipment & Materials

Industry comparison
Company Market cap ($B) P/E EV/EBITDA Gross Margin % EBIT Margin % Sales Growth (Year) % Perf. 1Y %
Acm Research Inc ACMR 4.6 48.7 12.7 43.8 15.6 15.2 100.7
Lam Research Corp LRCX 371.4 47.0 41.9 50.5 35.0 23.7 122.2
Applied Materials Inc AMAT 331.4 36.5 31.3 49.4 31.9 4.4 135.6
KLA Corporation KLAC 220.8 46.0 37.8 61.3 41.2 23.9 71.6
Teradyne Inc TER 57.6 59.4 34.3 59.2 37.6 13.1 209.5
Qnity Electronics, Inc Q 24.5 47.5 20.3 46.2 22.8 9.7 20.8
Entegris Inc ENTG 22.4 69.9 25.9 45.6 18.0 -1.4 41.1
Onto Innovation Inc ONTO 13.7 109.7 49.6 55.5 16.8 1.8 115.5
Amkor Technology Inc AMKR 11.9 23.7 8.5 15.5 6.0 6.2 81.4
Median of companies shown 24.5 47.5 31.3 49.4 22.8 9.7 100.7

Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →

Fiscal years

Annual Figures

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

Revenue, operating income and net income per fiscal year $M

Revenue Operating income Net income

2016 · Revenue: 27 $M 2016 · Operating income: 3 $M 2016 · Net income: 1 $M 2017 · Revenue: 37 $M 2017 · Operating income: 1 $M 2017 · Net income: 0 $M 2018 · Revenue: 75 $M 2018 · Operating income: 6 $M 2018 · Net income: 7 $M 2019 · Revenue: 108 $M 2019 · Operating income: 18 $M 2019 · Net income: 19 $M 2020 · Revenue: 157 $M 2020 · Operating income: 21 $M 2020 · Net income: 19 $M 2021 · Revenue: 260 $M 2021 · Operating income: 39 $M 2021 · Net income: 38 $M 2022 · Revenue: 389 $M 2022 · Operating income: 59 $M 2022 · Net income: 39 $M 2023 · Revenue: 558 $M 2023 · Operating income: 96 $M 2023 · Net income: 77 $M 2024 · Revenue: 782 $M 2024 · Operating income: 151 $M 2024 · Net income: 104 $M 2025 · Revenue: 901 $M 2025 · Operating income: 109 $M 2025 · Net income: 94 $M
2016201720182019202020212022202320242025
Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 27 3 1 0.04 -4 -2 44
2017 37 1 0 -0.01 -8 40 68
2018 75 6 7 0.12 7 52 103
2019 108 18 19 0.33 9 97 218
2020 157 21 19 0.30 -14 141 341
2021 260 39 38 0.58 -40 676 1,052
2022 389 59 39 0.60 -62 675 1,236
2023 558 96 77 1.19 -75 767 1,491
2024 782 151 104 1.56 152 905 1,856
2025 901 109 94 1.40 -10 1,464 2,872

Quarters

Quarterly Figures

Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 223.5 $M Q4 2025: Q1 · 172.3 $M Q1 2025: Q2 · 215.4 $M Q2 2025: Q3 · 269.2 $M Q3 2025: Q4 · 244.4 $M Q4 2026: Q1 · 231.3 $M Q1 2026: Q2 · 292.9 $M Q2

Source: fundamental data

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 0.47 74.00 224 31.20 13.90 89 76
2025: Q1 0.30 15.70 172 13.20 11.80 5 -12
2025: Q2 0.44 22.20 215 6.40 13.80 -45 -60
2025: Q3 0.52 13.20 269 32.00 13.30 -5 -16
2025: Q4 0.12 -75.00 244 9.40 3.30 34 19
2026: Q1 0.25 -18.50 231 34.20 7.50 -30 -52
2026: Q2 1.23 179.50 293 36.00 30.40 -6 -72

What Do These Terms Mean?

EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Compare with other stocks →

Screening

Appears in These Scanners

This stock currently matches 27 of our scanner strategies — each hit links to the scanner.

Growth

Quality & Balance Sheet

Breakout & Setup

Momentum & Trend

Research

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Outlook

Analysts & Price Target

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Consensus Sell 1 = Strong buy … 5 = Strong sell
Analyst Ratings 9
Price Target (average) 117.75$
Distance to price 73.7% The price target sits 73.7% above the current price.

Distribution of Recommendations

Strong Buy 4
Buy 4
Hold 1
Sell 0
Strong Sell 0

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
12/31/2026 2.15 1.90 – 2.59 1,171 33.8% 4
12/31/2027 2.89 2.65 – 3.44 1,515 34.3% 4

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Valuation

What is priced in?

Free cash flow over the past twelve months is negative, which rules out a serious reverse calculation. Any growth rate only makes a negative cash flow more negative; no present value comes out of it. What the price reflects here is therefore not a stream of cash flows, but the expectation that there will be one at all.

A simplified model calculation — not a forecast and not a recommendation.

AI classification

AI Rating

Neutral

Geprüft am 17.07.2026: In den ausgewerteten SEC-Berichten von ACM Research (CIK 1680062; 4×10-Q bis zum 31.03.2026 und 2×10-K für 2025/2024) findet sich kein wesentlicher KI-Bezug im Sinne des Kriterienkatalogs. ACM Research verkauft Reinigungs-, Galvanik-, Ofen- und Packaging-Anlagen für Chipfabriken — die Filings weisen weder KI-Produkte noch KI-Dienste als Umsatzquelle aus, belegen keinen operativen KI-Einsatz und nennen KI auch nicht als konkretes Risiko fürs eigene Geschäftsmodell. Sämtliche „artificial intelligence“-Treffer in beiden 10-K stehen ausschließlich in regulatorischen Passagen: erstens zum US-Outbound-Investment-Programm („the framework imposes notification requirements and prohibitions on specified investments by U.S. persons in the semiconductor and microelectronics sector, quantum information technologies, and artificial intelligence (AI) systems“ — übersetzt: „das Regelwerk verhängt Meldepflichten und Verbote für bestimmte Investitionen von US-Personen im Halbleiter- und Mikroelektroniksektor, bei Quanteninformationstechnologien und bei Systemen der Künstlichen Intelligenz (KI)“), zweitens zur BIS-Exportkontrollrunde vom Dezember 2024 („the U.S. BIS imposed additional controls on exports … relating to advanced integrated circuit products, certain IC manufacturing equipment and technology, and supercomputers associated with artificial intelligence (AI) and advanced computing“ — übersetzt: „das US-BIS verhängte zusätzliche Exportkontrollen … für fortgeschrittene IC-Produkte, bestimmte IC-Fertigungsanlagen und -technologie sowie Supercomputer im Zusammenhang mit Künstlicher Intelligenz (KI) und Hochleistungsrechnen“), in deren Zuge die Töchter ACM Shanghai und ACM Korea auf die Entity List kamen. Das ist Exportkontroll- bzw. Investitionsregulierung, kein KI-Geschäftsrisiko im Sinne von „bedroht“. Die vier ausgewerteten 10-Q (31.03.2026, 30.09.2025, 30.06.2025, 31.03.2025) enthalten keinerlei KI-Treffer; die Nachfrage begründet der 10-Q zum 31.03.2026 mit der Lokalisierungs-Strategie der festlandchinesischen Kunden, nicht mit KI. Nach dem Kriterienkatalog bleibt es bei „neutral“.

View the full file — quotes, sources, reviewed filings

Filings Reviewed: 10-Q 2026-05-08 · 10-Q 2025-11-06 · 10-Q 2025-08-07 · 10-Q 2025-05-12 · 10-K 2026-03-02 · 10-K 2025-03-03

Rated on July 17, 2026 · How the Rating Is Built

Growth

Growth Score

Ten checks against the annual reports — each one passed counts a point.

6 of 10 Solid growth
  • Revenue grows by more than 15% a year over three years 32.3%
  • More than 10% revenue growth is expected for the coming year 25.4%
  • Share count grows by less than 3% a year 1.0%
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 7.9%
  • Gross margin at 40% or higher and without meaningful erosion 44.4%
  • Goodwill from acquisitions does not grow faster than revenue 0.0%
  • Net debt below twice EBITDA 865 m net cash
  • Operating cash flow covers the profits of the last three years -208 m
  • Return on capital at 15% or higher, or up versus two years ago 5.2%
  • Insiders hold at least 10% or are net buyers 12.8%

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Quality check

AAQS

7/10

The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).

  • Sales growth 10Y > 5% 47.4%
  • Exp. sales growth 3Y > 5% 29.6%
  • EBIT growth 10Y > 5% 46.6%
  • Exp. EBIT growth 3Y > 5% 43.9%
  • Net debt < 4x EBIT -7.9x
  • EBIT positive, 10Y straight 10
  • Max. EBIT decline < 50% 79.9%
  • Return on equity > 15% 6.4%
  • ROCE > 15% 5.1%
  • Expected return > 10% 41.8%

View stocks with the full AAQS score · Read the methodology at AlleAktien

Source: fundamental data

Insiders

Insider Transactions

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

Insider Transactions
Date Person Role Type Shares Price Value
Sep 9, 2026 Wang David H See Remarks Sell 1,100 77.59 85,349
Sep 9, 2026 Wang David H See Remarks Sell 4,807 76.73 368,841
Sep 9, 2026 Wang David H See Remarks Sell 11,666 75.58 881,716
Sep 9, 2026 Wang David H See Remarks Sell 18,934 74.67 1,413,802
Sep 9, 2026 Wang David H See Remarks Sell 33,493 73.80 2,471,783
Sep 9, 2026 Wang David H See Remarks Other 70,000 1.00 70,000
Sep 8, 2026 Wang David H See Remarks Sell 1,500 78.57 117,855
Sep 8, 2026 Wang David H See Remarks Sell 12,323 78.08 962,180
Sep 8, 2026 Wang David H See Remarks Sell 51,374 77.15 3,963,504
Sep 8, 2026 Wang David H See Remarks Sell 4,803 75.99 364,980

View all insider transactions →

The company

About the Company

ACM Research, Inc. entwickelt, fertigt und verkauft gemeinsam mit ihren Tochtergesellschaften Investitionsgüter in Festlandchina und international.

CEO Insider Trades (12 Mo.)
selling own stock
Employees
2,513
Headquarters
Fremont, CA
Address
42307 Osgood Road, 94539 Fremont, United States
Phone
510 445 3700
Website
acmr.com
IPO Date
11/03/2017
ISIN
US00108J1097
Stock Split
959692:319897 on 03/24/2022

Management

Management
Name Title Birth Year
Hui Wang Ph.D. Founder, Chairman, CEO & President 1961
Mark A. McKechnie CFO, Executive VP, Secretary & Treasurer 1967
Yi Lu Feng Chief Financial Officer of ACM Research (Shanghai), Inc. 1958
Jian Wang Chief Executive Officer and President of ACM Research (Shanghai), Inc. 1965
Howard Chen General Counsel & VP of Corporate Strategy
Jim Straus Vice President of Sales - North America
Sotheara Cheav Senior Vice President of Manufacturing 1952

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Filings

Company Filings (8-K)

An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).

  • 08/27/2026 ACM Research, Inc. (ACMR): Other Events; Financial Statements and Exhibits SEC ↗
  • 08/07/2026 ACM Research, Inc. (ACMR): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?